Navigation Links
Chemo Alone Is Best for Advanced Colon Cancer
Date:5/30/2009

Better drugs have rendered surgery unnecessary in most cases, study finds

SATURDAY, May 30 (HealthDay News) --Surgery is no longer the best treatment option for most patients with advanced colorectal cancer that has spread to other organs, a new study suggests.

Immediate colon resection (surgical removal) following diagnosis of stage IV metastatic colorectal cancer had previously been the standard procedure, followed by chemotherapy several weeks after the operation. Surgery was thought to guard against symptoms and complications from the primary tumor, which chemotherapy was thought not to affect.

However, "if the colon tumor is not causing obstruction, perforation or bleeding we've found these patients are best treated with chemotherapy. By moving straight to chemotherapy, patients can avoid the risk of surgical complications and can start treatment for all sites of disease without delay," study author Philip Paty, a surgical oncologist at Memorial Sloan-Kettering Cancer Center, said in a news release issued by the center.

The recommendation is based on a finding that 93 percent of advanced metastatic colorectal cancer cases treated over a six-year period at Sloan-Kettering did not present the complications that failure to remove the primary tumor were expected to cause. Advances in chemotherapy that do a better job at shrinking both the primary colon tumor and the metastases are thought to be responsible for this change.

"We now know that the routine use of surgery for these patients is based on old thinking, and we're beyond that. There will always be the need for individual exceptions based on the clinical situation, but our default position should be not to operate," said Paty, who plans to present the findings Saturday at the American Society of Clinical Oncology annual meeting, in Orlando, Fla.

Colorectal cancer is the second leading cause of cancer-related death in the United States.'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Chemotherapy combination outcomes differ for aged, younger colon cancer patients
2. Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy
3. A New Way to Get Chemo to Pancreatic Tumors
4. Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma: Phase I/II and Phase II Studies, ASCO 2009
5. Ginger Eases Nausea From Chemo
6. Study shows chemotherapy improves survival among older breast cancer patients
7. Chemotherapy Superior to New Drug for Early Breast Cancer
8. Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa
9. 3-Drug Combo Reduces Nausea After Chemo
10. Delivering Chemo Directly Into Brain Tumors Shows Promise
11. Chemo Combo Shows Promise Against Ovarian Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemo Alone Is Best for Advanced Colon Cancer
Chemo Alone Is Best for Advanced Colon Cancer
(Date:12/3/2009)... , PLAINSBORO, N.J., Dec. 3 ...rinceton at Plainsboro (UMCPP) reached a milestone...completion of steel-frame construction at the new ...er at Princeton (UMCP). ,, (Photo: http://www....A topping out ceremony is a steelworkers, traditio...
(Date:12/3/2009)... , BEVERLY HILLS, Calif., Dec. 3 /PRNewswir...is year,s Divine Design Gala and Premier Shopping ... be priced at 50-70% off regular prices. The even...gh Monday, December 7, 2009, located at 9900 Wilsh...lls, California. Please visit www.divinedesign.o...
(Date:12/3/2009)... Mario Badescu Skin Care,s c...for as one of 55 products receiving a 2009 ELLE Be...mber 3, 2009 -- Mario Badescu Skin Care,s Drying L...ies, beauty industry insiders, and skin care divas...E Beauty Award marks a considerable leap into the ...
(Date:12/3/2009)...ding could aid in eventual development of screenin..., Dec. 3 (HealthDay News) -- New research points t...n D and heart disease. , People with high blood...min D activation in the body were found to be twic...ongestive heart failure, the study found. , The...
(Date:12/3/2009)... , PHOENIX, Dec. 3 The day ha...om the nation,s most prominent direct-care RN orga...7 for the founding convention of the new 150,000-m... and professional association in U.S. history. ,... keynote address to the convention which will char...
Breaking Medicine News(10 mins):Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4Health News:Christian Audigier Represented at Divine Design for Project Angel Food 2Health News:Vitamin D May Be Tied to Heart Disease Via Genes 2Health News:RN SuperUnion Founding Convention Opens Monday 2
... Quarter and Year-end Highlights, - Transitioned ...osed on, two ventures owning more than $320 milli... real estate.,- Generated net income in...al Inc., an affiliate of, Credit Suisse Securities...
...Speculative Buy, $0.51 Price Target, DALLAS, Marc... leading healthcare staffing company, today announ...t investment research firm,initiated coverage on t...investor/ and through, http://www.wassermanmorris...
...onto, ON. - Unconscious prejudices among doctors m...less likely than men to be recommended for total k...of the Canadian Medical Association Journal sugges... same symptoms of knee pain. The patients receive...
... YORK, MARCH 6, 2008 A new pilot study by investi...MSKCC) found that breast cancer patients can be tr... chemotherapy agents and the antibody trastuzumab ...reatments including trastuzumab and anthracyclines...
...n Trophy Winner and 2008 Red Cross National Celebr...ELES, Calif., March 10 Arizona,Cardinals Quarterb...net,Member, Matt Leinart, hosted a press conferenc...ted external,defibrillator.), During the press co...
...ORTH, N.J., March 10 Schering-Plough,Corporation ... a presentation,by Fred Hassan, chairman and Chief...h Annual Global Healthcare Conference in Miami, Fl...Sciences N.V., acquired in November 2007., A live...
Other Medicine News:Health News:Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results 2Health News:Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results 3Health News:Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results 4Health News:Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results 5Health News:Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results 6Health News:Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results 7Health News:Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results 8Health News:Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results 9Health News:Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results 10Health News:Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results 11Health News:Wasserman Morris Initiates Research Coverage on Crdentia 2Health News:Gender bias may affect care of people with osteoarthritis, study finds 2Health News:Professional Quarterback Matt Leinart Teams Up With American Red Cross to Promote CPR/AED Awareness 2
(Date:12/3/2009)...3 /PRNewswire-Asia/ -- Simcere Pharmaceutical Grou...eading pharmaceutical company,specializing in the ...ed,generic and proprietary pharmaceuticals in Chin... Administration ("SFDA") has initiated a comprehen...uman use rabies vaccine (vero,cell) manufactured b...
(Date:12/3/2009)...ssachusetts, December 3 ...oday announced that the Bavarian Red Cross has cho...Rettungswagen) medical vehicles. The use of capnog...lation status of a patient as well as alert them t...splaced endotracheal tubes, episodes of respirator...
(Date:12/3/2009)...er 3 After two decades of scientif..., Lightlake Therapeutics, experts,have been grante...ting,subjects for a trial of a simple, safe and ef...sation has described as a global epidemic of unhea...al for the everyday treatment against obesity and ...
Breaking Medicine Technology:Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 2Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5SupportSight Comes to West Chester Saturday September 26th 3B Free Seminar for Those Affected by Macular Degeneration 56386 1SupportSight Comes to West Chester Saturday September 26th 3B Free Seminar for Those Affected by Macular Degeneration 56386 2Inspiring New Online Destination From Bayer Diabetes Care 13896 1Inspiring New Online Destination From Bayer Diabetes Care 13896 2Inspiring New Online Destination From Bayer Diabetes Care 13896 3BioMarin to Present at the Morgan Stanley Healthcare Conference 13892 1BioMarin to Present at the Morgan Stanley Healthcare Conference 13892 2
...N DIEGO, June 16 Nventa Biopharmaceuticals,Corpor...s vice president of,corporate development, Richard...y overview at the Business Forum during the Biotec...onvention being held in San Diego,California, July...Wednesday, June 18, 2008, at 3:45 p.m. PDT in Room...
...N DIEGO, June 16 Patient enrollment into the GRAV...ssay-Impact On Thrombosis And,Safety) trial has be...he,GRAVITAS trial is designed to evaluate the use ...hat exhibit a low response to antiplatelet therapy...rove that these at-risk,patients will benefit from...
Other Medicine Technology:Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial 2Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial 3
van Andel Catheter
Whistle-tip Ureteral Catheters (Left Ureter)
Open-ended Tapered Tip Ureteral Catheter (Right Ureter)
Delta Wire Grasper
Medicine Products: